TACE versus TARE for patients with hepatocellular carcinoma: Overall and individual patient level meta analysis.

Andrew M Brown,Ihab Kassab,Marco Massani,Whitney Townsend,Amit G Singal,Cigdem Soydal,Laura Moreno-Luna,Lewis R Roberts,Vincent L Chen,Neehar D Parikh

Cancer medicine（2023）

引用 9|浏览15

暂无评分

摘要

Current data suggest TARE provides significantly longer TTP than TACE, although the two treatments do not significantly differ in terms of OS. Given limitations of the current data, there is rationale for prospective studies comparing these modalities.

查看译文

关键词

HCC,TACE,Y-90,locoregional therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要